Enzolytics Inc.
OTC:ENZC
0.02176 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.053 | 0 | 0.2 | 0 | 0 | 0.005 | 0.19 | 0 | 0 | 0.037 | 0.015 | 0.006 | 0 |
| Cost of Revenue
| 0.022 | 0.022 | 0.017 | 0.017 | 0.017 | 0.017 | 0.741 | 0.019 | 0.019 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.031 | -0.022 | 0.183 | -0.017 | -0.017 | -0.012 | -0.551 | -0.019 | -0.019 | 0.037 | 0.015 | 0.006 | 0 |
| Gross Profit Ratio
| 0.582 | 0 | 0.915 | 0 | 0 | -2.362 | -2.901 | 0 | 0 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 0.172 | 0.568 | 0.117 | 0.502 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.9 | 0.937 | 0.394 | 0.04 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.008 | 2.314 | 1.474 | 2.785 | 0.645 | 1.695 | 0.265 | 0.045 | 5.023 | 2.9 | 0.937 | 0.394 | 0.04 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.292 | 0 | 0 | 0 |
| Operating Expenses
| 2.18 | 2.882 | 1.59 | 3.286 | 0.645 | 1.695 | 0.265 | 0.045 | 5.023 | 2.912 | 0.95 | 0.403 | 0.043 |
| Operating Income
| -2.149 | -2.904 | -1.411 | -3.303 | -0.662 | -1.707 | -0.816 | -0.064 | -5.043 | -2.875 | -0.935 | -0.397 | -0.043 |
| Operating Income Ratio
| -40.7 | 0 | -7.054 | 0 | 0 | -341.348 | -4.295 | 0 | 0 | -77.771 | -63.599 | -69.863 | 0 |
| Total Other Income Expenses Net
| -0.028 | -0.037 | 0.741 | -0.177 | 1.583 | -0.051 | 0.759 | -0.489 | -0.025 | -4.639 | -0.034 | -0.029 | -0.357 |
| Income Before Tax
| -2.177 | -2.941 | -0.669 | -3.481 | 0.92 | -1.758 | -0.057 | -0.553 | -5.067 | -7.514 | -0.97 | 0 | -0.4 |
| Income Before Tax Ratio
| -41.231 | 0 | -3.347 | 0 | 0 | -351.545 | -0.301 | 0 | 0 | -203.255 | -65.936 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0 | -0 | -0 | 0 | -0 | -0.004 | -0.019 | -3.223 | 0 | 0.029 | 0.378 |
| Net Income
| -2.177 | -2.941 | -0.669 | -3.481 | 0.92 | -1.758 | -0.057 | -0.55 | -5.048 | -7.514 | -0.97 | -0.426 | -0.422 |
| Net Income Ratio
| -41.231 | 0 | -3.347 | 0 | 0 | -351.545 | -0.301 | 0 | 0 | -203.255 | -65.936 | -74.899 | 0 |
| EPS
| -0.001 | -0.001 | -0 | -0.004 | 0.001 | -0.005 | -0 | -0.005 | -0.044 | -541.66 | -256.63 | -118.91 | -155.29 |
| EPS Diluted
| -0.001 | -0.001 | -0 | -0.004 | 0.001 | -0.005 | -0 | -0.005 | -0.044 | -541.66 | -256.63 | -118.91 | -155.29 |
| EBITDA
| -2.122 | -2.882 | -0.612 | -3.286 | 1.056 | -1.69 | 0.327 | -0.045 | -5.023 | -7.433 | -0.922 | -0.388 | 0.317 |
| EBITDA Ratio
| -40.193 | 0 | -3.059 | 0 | 0 | -337.985 | 1.723 | 0 | 0 | -201.055 | -62.695 | -68.303 | 0 |